Navigation Links
Wayne State to develop a computer-delivered intervention for alcohol use during pregnancy
Date:10/26/2011

DETROIT -- A team of researchers at Wayne State University's Parent Health Lab in the School of Medicine have received a three-year grant to develop a computer-delivered intervention for pregnant women at risk for alcohol use, which can lead to lifelong negative effects on the fetus. Prenatal exposure to alcohol affects attentional, cognitive, social and behavioral functioning and is a major cause of mental retardation. Infants born to African American women are at increased risk of adverse effects.

Screening, brief intervention, and referral for treatment ("SBIRT") approaches to alcohol use during pregnancy can be used by medical staff to identify and reduce alcohol use among pregnant women. SBIRT approaches are not often used, however, because of the amount of time, training, expertise and commitment required. Computer-delivered SBIRT approaches may offer an alternative approach through the use of consistent screening and evidence-based brief interventions at a lower cost, without requiring significant time of medical staff.

With this in mind, the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health recently funded the "Healthy Pregnancy Study," which will help Steven Ondersma, Ph.D., associate professor of psychiatry and behavioral neurosciences, and colleagues develop and test a highly practical, high-reaching computer-delivered intervention to reduce alcohol use during pregnancy.

Ondersma's study will lay the groundwork for larger-scale investigations of computer-delivered SBIRT for alcohol use during pregnancy. Ondersma and his team will evaluate the utility of handheld mobile devices and an anonymous self-interview format in screening for at-risk drinking among patients at a prenatal clinic, along with sophisticated interactive intervention software. In addition, the study will examine the validity of the alcohol biomarker, Ethyl Glucuronide (EtG), to indicate alcohol exposure in study participants.

"If our study is successful, health care systems will have the ability to help far more at-risk women through this intervention than previously possible," said Ondersma. "In turn, it may also have a meaningful impact on reducing Fetal Alcohol Spectrum Disorders."


'/>"/>
Contact: Julie O'Connor
julie.oconnor@gmail.com
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Wayne State University study of heroin users to examine links between stress, drug use
2. Wayne State University to study effects of risky family environments on childhood asthma
3. Wayne State researcher developing treatments for Parkinsons with aid of $2.15 million NIH grant
4. Wayne State University study aims to improve diabetes management in high-risk youth
5. Wayne State University partners with Toyota on safety research
6. Wayne State University researcher to study spinal muscular atrophy
7. Wayne State University awarded $3 million from NIH to foster science and research careers
8. Wayne State researcher receives NSF award to develop neural implants
9. Wayne State University engineering student receives American Tinnitus Association award
10. Wayne State University researcher argues that sex reduces genetic variation
11. Health providers should emphasize breast cancer screening, Wayne State University research finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: